Phase 4 Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT07268820)

Phase 4 Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07268820 Sponsor: Incheon St.Mary's Hospital Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07268820 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 19 years or older who are Korean residents, as of the date of signing consent
People who have been diagnosed with erosive gastroesophageal reflux disease (a condition where stomach acid damages the lining of the food pipe) confirmed by a camera examination of the upper digestive tract
People who have experienced heartburn at night for more than 3 months at the time of their first screening visit
People who have made a voluntary decision to take part and have signed a written consent form

Who may not be able to join:

People who are unable to undergo a camera examination of the upper digestive tract
People with a history of drug or alcohol misuse within the past year
People who have taken part in another clinical trial and received an investigational product within one month before the screening visit
People who have other health findings that the trial doctor considers medically unsuitable for this study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +82-1544-9004

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07268820

Sponsor: Incheon St.Mary's Hospital

Phase: Phase 4

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

Trial contact: +82-1544-9004

More information: https://clinicaltrials.gov/study/NCT07268820

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 19 years or older who are Korean residents, as of the date of signing consent
People who have been diagnosed with erosive gastroesophageal reflux disease (a condition where stomach acid damages the lining of the food pipe) confirmed by a camera examination of the upper digestive tract
People who have experienced heartburn at night for more than 3 months at the time of their first screening visit
People who have made a voluntary decision to take part and have signed a written consent form

Who may not be able to join:

People who are unable to undergo a camera examination of the upper digestive tract
People with a history of drug or alcohol misuse within the past year
People who have taken part in another clinical trial and received an investigational product within one month before the screening visit
People who have other health findings that the trial doctor considers medically unsuitable for this study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Incheon St.Mary's Hospital

Registry

ClinicalTrials.gov

Start date

7 July 2025

Est. completion

29 May 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Proportion of participants without sleep disturbance related to nighttime heartburn during the last 7 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov